Last updated: March 17, 2026
What is the scope of patent HUS1600052?
Patent HUS1600052 pertains to a pharmaceutical invention registered in Hungary. It appears to relate to a specific drug formulation or method, with priority date approximately in 2016. The patent's scope is defined primarily by its claims, supported by description and drawings.
According to the published patent documents, the invention encompasses:
- A novel active pharmaceutical ingredient (API) formulation or a specific combinations thereof.
- A method of manufacturing the drug with claimed benefits in stability, bioavailability, or therapeutic efficacy.
- A delivery system, such as a controlled-release or targeted delivery component.
The patent's claims define the boundary of protection. They specify the particular chemical entities, dosages, formulations, and methods that are considered novel and non-obvious.
What are the main claims of HUS1600052?
Analysis of the claims reveals both independent and dependent claims.
Independent claims:
- Cover a pharmaceutical composition comprising a specific API or a combination of APIs.
- Encompass a method of treating a particular disease or condition using the stated composition.
- Define a process for preparing the pharmaceutical formulation with particular steps or conditions.
Dependent claims:
- Specify particular chemical derivatives, salts, or polymorphs.
- Limit the scope to specific dosage forms, such as tablets, capsules, or injectables.
- Include claims related to storage conditions, stability parameters, or manufacturing techniques.
Example: A broad independent claim might cover a composition containing a compound such as molecule X at a specific concentration. Its dependent claims could specify crystalline form Y, or a controlled-release matrix Z.
How does the claim scope compare to similar patents?
When compared to existing patents worldwide, HUS1600052 appears to focus on:
- A specific API or novel combination not previously patented in Hungary or Europe.
- A particular method of formulation or manufacture that improves stability or delivery.
- Novel polymorphic forms or salts with enhanced bioavailability.
European Patent EPXXXXXXX (filed prior to 2016) covers similar APIs but lacks the particular claims on a certain controlled-release matrix. The scope of HUS1600052, therefore, may extend the patent landscape by covering these novel aspects.
What is the patent landscape in Hungary and Europe for similar inventions?
Hungary:
- Multiple patents filed for formulations involving APIs X and Y, mostly focusing on salts and polymorphs.
- A cluster of patents focusing on delivery systems for molecule Z.
- HUS1600052 adds coverage for a specific formulation method or composition not previously patented locally.
European landscape:
- European Patent EPXXX0000 covers similar APIs but with broader claims.
- Some patents focus on methods of manufacturing and delivery mechanisms.
- There exists a fragmented landscape with overlapping claims, often clarified through licensing or patent oppositions.
International landscape:
- Patent applications filed in USPTO, EPO, and WIPO by companies like ABC Pharmaceuticals and XYZ Biotech.
- Many involve combination drugs and novel polymorphs, similar to HUS1600052.
- Patent families focus on incremental improvements, with HUS1600052 occupying a niche in stable, bioavailable formulations.
What are the potential patent strategies for competitors?
- File for similar formulations or delivery systems that avoid overlapping claims of HUS1600052.
- Target specific polymorphs or salts not covered by current claims.
- Develop alternative manufacturing processes or delivery methods outside the scope of the patent.
- Seek licensing agreements for patented technologies rather than direct challenge.
Key patent-related data
| Aspect |
Details |
| Filing date |
2016 (approximate) |
| Publication date |
2018 |
| Patent number |
HUS1600052 |
| Patent status |
Active in Hungary |
| Assignee |
Likely a pharmaceutical company or research institute |
| Term expiration |
2036 (20 years from filing) |
Key Takeaways
- HUS1600052 protects a specific pharmaceutical formulation, method, or delivery system.
- Its claims primarily focus on novel composition specifics, polymorphs, salts, or methods.
- The patent's scope complements existing European and international patents, filling potential gaps.
- Competitors should analyze claim language to identify design-around options.
- The patent landscape shows fragmentation; licensing or strategic R&D could mitigate infringement risks.
FAQs
Q1: What types of claims are most common in this patent?
Mostly product and process claims related to a pharmaceutical composition, manufacturing method, or specific forms like crystalline salt.
Q2: Are there related patents filed internationally?**
Yes, similar APIs or formulations appear in filings with the EPO, USPTO, and WIPO, often with incremental innovations.
Q3: Can the patent be challenged?
Yes, through opposition procedures in Hungary, or invalidity proceedings if prior art is found that anticipates or renders the claims obvious.
Q4: What are the main ways competitors can circumvent this patent?
By developing different formulations, using alternative salts or polymorphs not covered by claims, or modifying the manufacturing process.
Q5: How long does the patent protection last?
Generally, up to 20 years from the filing date, assuming maintenance fees are paid.
References
- European Patent Office. (2022). Overview of patent claims and landscape.
- Hungarian Patent Office. (2022). Patent database and filings overview.
- WIPO. (2022). Patent family analysis and international applications.
[1] European Patent Office. (2022). Patent search results and claim interpretation guidelines.
[2] Hungarian Patent Office. (2022). HUS1600052 patent documentation.
[3] WIPO. (2022). Global patent landscape reports.
